Targeting the NMDA Glutamate Receptor as Novel Antidepressant Strategy: A Pilot Clinical Trial of Nuedexta in Treatment-Resistant Major Depression
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2018
Price : $35 *
At a glance
- Drugs Dextromethorphan/quinidine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 19 Apr 2016 Status changed from recruiting to completed.
- 04 May 2015 Planned End Date changed from 1 Jun 2015 to 1 Jan 2016 as reported by ClinicalTrials.gov.
- 09 Jul 2013 New trial record